Rosna Mirtcheva, MD
Radiologist & Nuclear Medicine Physician
Breast Cancer; Lymphoma; Melanoma; Lung Cancer; Gynecologic Malignancies; Colorectal Cancer; Multiple Myeloma; Positron Emission Tomography/Computed Tomography (PET/CT); General Diagnostic and Therapeutic Nuclear Medicine; General Diagnostic Radiology
We post reviews for MSK healthcare providers who have at least 30 patient experience surveys completed. If you do not see reviews for a provider, it may be because they do not yet have enough survey responses, or the provider may not be part of the group of healthcare providers included in the survey.
Only outpatient providers are included in the survey. Healthcare providers who only work in the hospital or in urgent care are not included in the survey. Pathologists or researchers who do not provide direct care to patients do not have reviews.
Contact and Location
Memorial Sloan Kettering has locations throughout New York City, Long Island, New Jersey, and Westchester. These locations offer many services, including screening, chemotherapy, and medical testing.
MD, Medical University of Varna
Nuclear Medicine - NewYork-Presbyterian Hospital/Weill Cornell Medical Center; Radiology - NewYork-Presbyterian Hospital/Weill Cornell Medical Center
PET/CT - NewYork-Presbyterian Hospital/Weill Cornell Medical Center
Radiology; Nuclear Medicine
As a dual board-certified diagnostic radiologist and nuclear medicine doctor, I am committed to excellence in oncologic imaging, clinical care, and teaching residents and fellows. I have more than 25 years of experience in the fields of radiology and nuclear medicine, with expertise in molecular oncologic imaging.
I provide clinical care by interpreting PET/CT scans and a broad variety of conventional nuclear medicine studies that are used for the diagnosis and staging of cancer, as well as to see how treatment has worked. I collaborate closely with medical oncologists, radiation oncologists, and surgeons to provide comprehensive and compassionate care for people with different types of cancer such as breast cancer, lung cancer, and lymphoma.
I trained in both Europe and the United States. My interest in radiology began in medical school. I became fascinated with advanced imaging techniques and their critical role in diagnosing cancer and managing the disease. Later, I was captivated by the molecular approach to imaging and targeted therapies, and molecular oncologic imaging became my main interest.
I have more than 25 years of experience in the fields of radiology and nuclear medicine, with expertise in molecular oncologic imaging.
Memorial Sloan Kettering's doctors and scientists are constantly developing new treatments for cancer. MSK is typically running hundreds of clinical trials at a given time.
You may be able to participate in a clinical trial even if you are new to MSK. Search our online directory to find trial information and see more about who can participate.
At MSK, we’re committed to delivering the best care to every patient. We use feedback from our patients to continue to improve our care. We also post patient reviews online to help you make healthcare choices. Learn more about our patient experience reviews.
Doctors and faculty members often work with pharmaceutical, device, biotechnology, and life sciences companies, and other organizations outside of MSK, to find safe and effective cancer treatments, to improve patient care, and to educate the health care community.
MSK requires doctors and faculty members to report (“disclose”) the relationships and financial interests they have with external entities. As a commitment to transparency with our community, we make that information available to the public.
Rosna Mirtcheva discloses the following relationships and financial interests:
No disclosures meeting criteria for time period
If you’re a patient at MSK and would like more information about your doctor’s external relationships, please talk with your doctor.
The information published here is for a specific annual disclosure period. There may be differences between information on this and other public sites as a result of different reporting periods and/or the various ways relationships and financial interests are categorized by organizations that publish such data.
This page and data include information for a specific MSK annual disclosure period (January 1, 2021 through disclosure submission in spring 2022). This data reflects interests that may or may not still exist. This data is updated annually.